NARI250117C50000
- 3.40
- -2.05-37.61%
Inari Medical Newsroom
Inari Medical to Present at the J.P. Morgan Healthcare Conference
Inari Medical(NARI.US) Director Sells US$3.34 Million in Common Stock
Truist Securities Raises Price Target on Inari Medical to $63 From $50, Keeps Hold Rating
Express News | Inari Medical Inc : Truist Securities Raises Target Price to $63 From $50
Oppenheimer Initiates Coverage On Inari Medical With Outperform Rating, Announces Price Target of $75
Inari Medical Analyst Ratings
Inari Medical Edges Higher Amid Takeover Speculation
Reasons to Retain Inari Medical Stock in Your Portfolio for Now
Okami Medical Appoints Bill Hoffman to Its Board of Directors
NARI Stock Likely to Gain Following Reimbursement Approval in Japan
Inari Medical Forms Joint Venture in Greater China
Express News | Inari Medical Inc - Clottriever System 510(K)-Cleared by FDA and Ce-Marked for Dvt
Inari Medical Announces Reimbursement Approval for ClotTriever Thrombectomy System in Japan and New Distribution Partnership With Medikit Co., Ltd.
Express News | Inari Medical Announces Reimbursement Approval for Clottriever® Thrombectomy System in Japan and New Distribution Partnership With Medikit Co., Ltd.
Express News | Inari Medical Announces Joint Venture in Greater China
Express News | Inari Medical Inc : Leerink Partners Raises Target Price to $52 From $48
Inari Medical(NARI.US) Director Sells US$3.07 Million in Common Stock
Insider Sale: Director at $NARI (NARI) Sells 9,750 Shares
Form 144 | Inari Medical(NARI.US) Director Proposes to Sell 6.07 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 18, $Inari Medical(NARI.US)$ Director WILLIAM HOFFMAN intends to sell 120K shares of its common stock on Nov 18, with a total market value of approximately $6.07 million.
Is Inari Medical (NARI) Trading at an Attractive Valuation?